• Jobs
  • Downloads
  • FAQ
  • Contact
  • Access
  • Deutsch Deutsch German de
  • English English English en
oncgnostics GmbH
  • GynTect & Cervical cancer
    • Information for patients
      • Cervical cancer
      • Cervical cancer diagnostics
      • What is GynTect doing?
      • More information
      • FAQ patients
      • Contact
    • Information for physicians
      • GynTect® test procedure
      • Screening algorithm
      • Trial data
      • FAQ physicians
      • Order request
    • Information for diagnostic laboratories
      • Test principle
      • Screening algorithm
      • Trial data
      • FAQ Labs
      • Order
  • For Investors / Partners
    • Press
    • Events / Talks
    • Professional opinions / statements
    • Investors and partners
    • Investors contact
  • About oncgnostics
    • About us
    • Management
    • Lab team
    • Advisory board
    • History
    • Pipeline
      • Ovarian cancer
      • Head and neck cancer
    • Access
    • Contact
    • Press
    • Jobs
  • News / Blog
  • Search
  • Menu

Information for physicians

In Germany, annually more than 200,000 women receive an abnormal Pap test result (Pap III or Pap IIID). They want clarity!

Our newly developed test GynTect® can contribute substantially to the clarification of this important question. GynTect® allows the detection of molecular markers which occur specifically in precancerous or cancer cells. Thus, the test allows to identify among the women with abnormal Pap smear and a positive HPV test result those who may develop or already have a dysplasia that leads to cancer.

New cervical cancer screening: 

In several European countries, such as the Netherlands, Germany, HPV-testing may be used in screening of women aged 30 years and older. Women with an HPV infection will then receive clarification by a suitable triage test, if the infection has already led to dysplastic changes with the potential to develop cervical cancer. With GynTect® we provide such a triage test.

  • Information for patients
    • Cervical cancer
    • Cervical cancer diagnostics
    • What is GynTect doing?
    • More information
    • Contact
    • FAQ patients
  • Information for physicians
    • GynTect® test procedure
    • Screening algorithm
    • Trial data
    • FAQ physicians
    • Order request
  • Information for diagnostic laboratories
    • Test principle
    • Screening algorithm
    • Trial data
    • FAQ Labs
    • Order

Recent Posts

  • Oncgnostics GmbH Presents New Clinical Data on GynTect® Precision Diagnostics at EUROGIN 2018
  • Cervical Cancer Screening: oncgnostics Closes further Investment Round
  • Oncgnostics GmbH retains Biotech Alliances International Inc. to support global partnering and distribution strategy.
  • oncgnostics in China: Pitch, Trade Fair, and Meeting with Partner
  • Test for Uterine Cancer in Portugal: Biotech Firm oncgnostics Grants Exclusive Licence for Cancer Screening Test

oncgnostics GmbH

The oncgnostics GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on epigenetic biomarkers.

oncgnostics GmbH is working according to ISO 13485 standards in research, development, production and management.

Our Topics

  • GynTect & Cervical cancer
  • Information for patients
  • Information for physicians
  • Information for diagnostic laboratories
  • Investors contact

Recent Posts

  • Oncgnostics GmbH Presents New Clinical Data on GynTect® Precision Diagnostics at EUROGIN 2018
  • Cervical Cancer Screening: oncgnostics Closes further Investment Round
  • Oncgnostics GmbH retains Biotech Alliances International Inc. to support global partnering and distribution strategy.
  • Show all Events

Contact

oncgnostics GmbH
BioInstrumentezentrum Jena
Winzerlaer Str. 2
07745 Jena
Germany

Phone: +49 (0)3641 508456
Fax: +49 (0)3641 508451

Email: contact[at]oncgnostics.com
Internet: www.oncgnostics.com

© 2015 - 2018 oncgnostics GmbH Jena Germany
  • Home
  • Imprint
  • Privacy policy
  • Contact

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn moreI accept
Scroll to top